Skip to content

Clinical trials

Diabetic Nephropathies trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Nephropathies Country / region: Hong Kong Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20121
20131
20143
20153
20161
20181
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting2
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer3
Pfizer2
The University of Hong Kong2
Asia Diabetes Foundation1
Boehringer Ingelheim1
Chinese University of Hong Kong1
Elaine Chow1
NephroGenex, Inc.1
University of Sydney1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Nephropathies13
Diabetes Mellitus, Type 25
Diabetes Mellitus4
Kidney Diseases3
Diabetes Mellitus, Type 12
Diabetic Retinopathy2
Renal Insufficiency, Chronic2
Albuminuria1
Cardiovascular Diseases1
Coronary Disease1

Trials

Showing 51 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.